Guangxi Nanning Luyida Maoyi Co.,Ltd – Trademark Portfolio

Entity Type: 16

Guangxi Nanning Luyida Maoyi Co.,Ltd holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include CARETHOS. The owner is based in Nanning.

Room 8, 23rd Floor, Modern International, No. 115-1 Minzu Avenue, Qingxiu District

Nanning 530000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

CARETHOS
CARETHOS
Registered 2025

Trademark Classifications

Guangxi Nanning Luyida Maoyi Co.,Ltd's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does Guangxi Nanning Luyida Maoyi Co.,Ltd have?

Guangxi Nanning Luyida Maoyi Co.,Ltd has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Guangxi Nanning Luyida Maoyi Co.,Ltd file in?

Guangxi Nanning Luyida Maoyi Co.,Ltd files trademarks across 1 Nice Classification class. The most active classes are Class 9 (Computers & Electronics). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are Guangxi Nanning Luyida Maoyi Co.,Ltd's most well-known trademarks?

Guangxi Nanning Luyida Maoyi Co.,Ltd's registered trademark portfolio includes well-known marks such as CARETHOS. These are among 1 currently registered trademark in the portfolio.

What is Guangxi Nanning Luyida Maoyi Co.,Ltd's trademark registration success rate?

Guangxi Nanning Luyida Maoyi Co.,Ltd has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.